External News Archives - Page 10 of 11

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/rosecapital41/wp-includes/functions.php on line 6114
External News Archives - Page 10 of 11 - Rose Capital

Cannabis-focused investment firm Rose Capital raises $55 mln for maiden fund

Rose Capital, a cannabis-focused investment firm, has closed its debut fund at $55 million. Rose Capital Fund I will focus on backing cannabis operators in the following sectors: consumer packaged goods; data and analytics; distribution and logistics; and ancillary products.

Helix TCS Inc. and Rose Capital Acquire 100% of the Preferred Stock of BioTrackTHC

GREENWOOD VILLAGE, CO, Feb. 06, 2018 (GLOBE NEWSWIRE) — Helix TCS, Inc. (OTCQB: HLIX), along with its investment partner Rose Capital, acquired all of the outstanding preferred stock of Bio-Tech Medical Software, Inc. (or BioTrackTHC). This investment represents approximately 18.5% of BioTrackTHC’s outstanding capital stock, on an as-converted to common basis. In addition, Helix CEO Zac Venegas will join BioTrackTHC’s board.